There were the following types of drugs used after cancer chemotherapy: 1. Medicines to relieve discomfort: For example, antiemetic drugs were used to relieve nausea and vomiting, immune boosters could improve the patient's physical condition, and there were also corresponding drugs to help relieve patients who felt tired and physically weak after chemotherapy. 2. Medicines to repair physical damage: For example, white blood cell growth factor and bone marrow stimulating factor can repair the damage caused by chemotherapy. For infection caused by low white blood cells, traditional Chinese medicine with heat-clearing, detoxifying, anti-inflammatory and anti-inflammatory effects can be used, such as honeysuckles, forsythia, dandelion, etc. 3. Medicines to relieve emotional symptoms: If the patient has anxiety, depression, and emotional instability after chemotherapy, antidepressors or sedatives can be given. 4. Traditional Chinese medicine conditioning drugs: After chemotherapy, the function of the spleen and stomach is damaged. You can use drugs such as dangshen, bai zhu, and poria cocos to nourish the spleen and stomach; drugs such as Huangqi, Angelica, and Shuhuang can directly supplement qi and blood and increase the number of white blood cells and blood panels. 5. Target drugs selected after individual testing: Through genetic testing related to chemotherapy drugs, appropriate targeted drugs can be selected according to the test results. Read more exciting novels for free
There were mainly the following types of chemotherapy drugs for lung cancer: 1. ** Platinum-based combination drug **: - Cisplatine or chemotherapy is often used in combination with other chemotherapy drugs. For example, the combination of chemotherapy and gemcitobin was a common treatment. 2. ** Other commonly used drugs **: - Paclitaxel-bound taxol was commonly used in clinical practice. However, some patients would have allergic reactions, so a drug sensitivity test had to be performed before taking the drug. - Etoposide. - Gemcitobin was more effective, but it was not recommended for patients who were receiving synchronous chemotherapy and chemotherapy, as it might cause complications such as lung edema. - Vinorelbine. - Docethereal, which can be used in combination with ramoirubin for second-line treatment of patients with metastasized non-small cell lung cancer (including squamous-cell lung cancer). 3. ** Medicines for special circumstances **: - Necitumamoto was approved for use in combination with cisplatinum-based therapy and gemcitabine-based therapy in patients with metastasizing squamous-cell lung cancer. - Afantine can be used in patients with metastasized squamous-cell lung cancer who have progressed after platinum-based chemotherapy. The use of these drugs must be carried out under the guidance of a doctor, and the choice of drugs will depend in part on factors such as the patient's overall health and ability to tolerate side effects. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
The liver-protecting drugs used for early chemotherapy of breast cancer included liver-protecting tablets, Glutathion tablets, Compound Ammine Glycerate injection, Diammine Glycerate Enteric capsules, Dicyclol tablets, and Yishanfu Polyene Phospholipidoline capsules. These drugs needed to be used under the guidance of a doctor. For example, liver-protecting tablets could protect the liver; Glutathione-based tablets could repair stem cells and detoxify; and compound licorice injection could protect the liver and improve the pain symptoms caused by liver damage. The bicyclol tablets had a good effect on reducing the index of Gu and C, but the effect on the index of Gu and Cao was not ideal. The Yishanfu Duoene Phospholidylcholin capsules did not improve the high index of transferment in some patients. Regarding the kidney protection drugs for early chemotherapy of breast cancer, the reference materials did not explicitly mention the relevant drugs. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
Domestically-produced breast cancer chemotherapy drugs such as pirotinib had strong efficacy, and clinical data crushed the imported drug lapatini. There were also taxol, trastuzumab, chemotherapy, etc. Among them, Utedron was the first and only approved epothilone anti-tumor drug in China. It was used for the treatment of relapsed and metastasized advanced breast cancer, breaking the long-term situation of no breakthrough chemotherapy drugs other than taxol in the treatment of advanced breast cancer in China. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
The more commonly accepted chemotherapy plan for stage 3 sigmoid cancer was the Xelox plan, which mainly consisted of two kinds of chemotherapy drugs. One was oxaliplatinum, which required intravenous infusion, and the other was oral capecitobin (Xeloda). The two drugs were used together. However, the specific chemotherapy plan and medication needed to be consulted with the doctor. The doctor would determine it based on the patient's physique and pathological examination results. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
The side effects of breast cancer chemotherapy drugs were as follows: 1. Bone marrow suppression: - White blood cell reduction was more common. For example, white blood cell reduction was more common after the use of cyclosporine, and the lowest value was 1 - 2 weeks after the use of cyclosporine. Most of them recovered after 2 - 3 weeks. The strength of bone marrow suppression caused by anthracyclines was higher than that of cyclosporine. Bone marrow suppression was more likely to occur when taxane drugs were used in combination with cyclosporine. Bone marrow suppression could lead to low white blood cells, low blood counts, and even leukemia. Neutropiuria could also be accompanied by infection. 2. ** Intestinal reaction **: - This included loss of appetite, nausea, vomiting, diarrhea, or constipation. Cyclocyclosporine's digestive tract reactions were manifested as loss of appetite, nausea and vomiting, which generally disappeared after stopping the drug for 1 - 3 days. Anthracyclines would cause digestive disorder, such as nausea, vomiting and diarrhea. The digestive tract reactions of taxane drugs were common but not serious, and a few could have diarrhea. 3. ** Cardiac toxicity (mainly due to anthracyclines)**: - The greater the dosage, the greater the cardiac toxicity. There were three types according to the time of appearance: - Acuteness: It often occurs within a few hours or days after administration, and is manifested as cardiac transmission disorder and cardiac arrest. In a few cases, it is manifested as pericarditis and acute left heart failure. - "Chronical: It occurs within 1 year of chemotherapy, and it is manifested as left cardiovascular malfunction, which can eventually lead to heart failure." - Late-onset: It occurs several years after chemotherapy, and may manifest as heart failure, myocardiopathic disease, and cardiac arrest. 4. ** Hair Loss **: - 60 - 90% of patients who took the anthracyclines would have hair loss, which was generally irreversible. After stopping the drug, hair would grow back; mild hair loss was more common with taxane drugs; taxol, a commonly used drug for breast cancer, could also cause hair loss. 5. ** Others **: - Cytoxan has urological reactions. If a large dose of cyclosporine is used and there is no effective preventive measures, it can cause bleeding cystitis, which is manifested as bladder irritation symptoms, oliguria, hematuria, and proteinuria. The occurrence rate is relatively low when the conventional dose is used. There may also be stomatitis, toxic leukemia, skin hyperchrominosis, menstrual disorder, and lung edema. Poisonous Poisonous (appearing on the side of the tongue and sub-tongue on the fifth to tenth day of medication). There were reports of occasional fever, chills, hives, hyperchromism, and joint pain; Allergy to yew drugs (Paclitaxel-like and taxotere can cause it, but not taxol. Pretreatment with hormones and other drugs is required before infusion. The drip rate can be adjusted for mild symptoms. For serious reactions, the drug should be stopped.), peripheral nervous system toxicity (Numbness of fingers and toes is the most common. Obvious sensory and motor disturbances and decreased tendon reflexes may occur at high doses. Grand mal seizure during infusion is reported in some cases.), cardiovascular toxicity (Temporary heart rate and low blood pressure are more common), joint and muscle pain (about half of the patients will feel pain 2 - 3 days after taking the medicine, which is related to the dosage and will recover within a few days. When combined with the White Increasing Needle, the muscle pain will worsen), changes in the liver and gallbladder system (such as elevation of Bilirubin, Alkaline Phosphatase, and Glutamate Oxalic Transaminases in some patients after taking taxol). In addition, chemotherapy drugs could also cause local reactions, such as phlebitis caused by chemotherapy drugs, local skin rupture and necrosis caused by drug exudate, as well as immune suppression, which would cause the body's immune function to be low and the resistance to infection. There were also internal organ damage, such as liver and kidney function damage. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
At present, there was no clear mention of which breast cancer chemotherapy drugs had fewer side effects. The common side effects of breast cancer chemotherapy drugs included digestive tract reactions, bone marrow suppression, hair loss, rash, impact on cardiac function, local inflammation, radiation inflammation, radiation inflammation, and so on. The side effects of different drugs were different, but there was no mention of which drug had fewer side effects. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
For patients with relapsed or metastasized head and neck cancer, the commonly used first-line chemotherapy drugs included platinum, 5 -flurfluralin, taxane, cetuxed, and methylethalin, but it was not easy to determine which drug was the "best". There are different recommended combinations for different situations and different tolerance levels: - The standard first-line treatment was platinum-based chemotherapy in combination with 5 -flurfluralin, taxane, or cetuxed. - For patients who could not tolerate 5 -fluralin, platinum/taxane in combination with cetuxed could be used; for patients who could not tolerate platinum, taxane in combination with cetuxed could be used; for patients who could not tolerate the combination therapy, platinum, taxane, methylethrin, cetuxed and other single agents could be used. - In second-line treatment, patients who had not used taxoids before could use taxoids in combination with cetuxed; patients who had not used cetuxed before could use cetuxed alone; others could use chemotherapy alone that had not been used in first-line treatment. In addition, in the rhythmic chemotherapy protocol, methylethalin could be used as a commonly used oral chemotherapy drug for head and neck cancer. In short, the choice of chemotherapy drugs needed to take into account the patient's general condition, tumor location, tumor stage, pathological type, and other factors, weighing the pros and cons of the treatment method. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
Commonly used strong stimulative chemotherapy drugs were Actinomycins D, Doxorubin, Daunorubin, Mitomycins C, Mustard, Plicalin, Vinincristine, Vinblastine, Vinincristine, Vinorelbine, ActD, ADC, MMCs, VDs, and so on. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
The drugs used to treat breast cancer had an effect on liver function. For example, among the commonly used chemotherapy drugs for breast cancer, cyclosporine may cause adverse reactions such as toxic hepatectomy, while anthracyclines may have side effects such as cardiac toxicity, bone marrow suppression, hair loss, myospasm, and gastric and intestinal disturbances. Although the effect on liver function was not explicitly mentioned, the overall toxicity of the drug may indirectly affect liver function. The main toxic reactions of taxane drugs were concentrated in blood toxicity, allergic reactions, peripheral nervous system toxicity, etc. However, multi-drug combination chemotherapy may also affect liver function. In addition, some breast cancer patients showed obvious liver damage after chemotherapy. Their transminase levels rose to more than 1000 (normally, it was only 40). This situation needed to be taken seriously and liver protection and supportive treatment should be carried out in time. It is recommended that the liver function should be checked regularly during the chemotherapy period. If there is damage, the liver protection should be given. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
It might be affected if she took some hormone drugs after chemotherapy. According to some studies, compared with the use of hormone therapy alone, chemotherapy before hormone therapy may increase the risk of cancer-related cognitive disorders in breast cancer patients, and it has nothing to do with menstrual status. From the perspective of the mechanism of action, chemotherapy drugs had a killing effect on the cells of the whole body, and they were more lethal to the cells that proliferated quickly. The mechanism of hormone therapy was to suppress the growth of breast cancer cells. When chemotherapy and hormone therapy were used at the same time, it would affect the lethality of the chemotherapy drugs to the tumor cells. Moreover, both chemotherapy drugs and hormonal drugs had side effects. If there were side effects when they were used together, it would be difficult to tell which drug caused it. However, hormonal therapy was the first choice for the first-line treatment of estrogen-receptor-positive breast cancer. For patients with hormone receptor-positive breast cancer, hormonal therapy could reduce the risk of relapse and metastasizing by suppressing the body's secretion of estrogens. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>